Last year, the pharmaceutical industry was able to sideline more than one legislative proposal it didn't like, including one designed to lower drug prices and another restricting direct-to-consumer ads. That's probably not a coincidence, however. Last year the industry's leading trade group, PhRMA, spent more than $22 million on lobbying, up 25 percent from 2006. Given the impending shifts in power, they may spend even more this year, Hill watchers predict. FiercePharma